Apolipoprotein A-I Adopts a Belt-like Orientation in Reconstituted High Density Lipoproteins*

Apolipoprotein A-I (apoA-I) is the major protein associated with high density lipoprotein (HDL), and its plasma levels have been correlated with protection against atherosclerosis. Unfortunately, the structural basis of this phenomenon is not fully understood. Over 25 years of study have produced two general models of apoA-I structure in discoidal HDL complexes. The “belt” model states that the amphipathic helices of apoA-I are aligned perpendicular to the acyl chains of the lipid bilayer, whereas the “picket fence” model argues that the helices are aligned parallel with the acyl chains. To distinguish between the two models, various single tryptophan mutants of apoA-I were analyzed in reconstituted, discoidal HDL particles composed of phospholipids containing nitroxide spin labels at various positions along the acyl chain. We have previously used this technique to show that the orientation of helix 4 of apoA-I is most consistent with the belt model. In this study, we performed additional control experiments on helix 4, and we extended the results by performing the same analysis on the remaining 22-mer helices (helices 1, 2, 5, 6, 7, 8, and 10) of human apoA-I. For each helix, two different mutants were produced that each contained a probe Trp occurring two helical turns apart. In the belt model, the two Trp residues in each helix should exhibit maximal quenching at the same nitroxide group position on the lipid acyl chains. For the picket fence model, maximal quenching should occur at two different levels in the bilayer. The results show that the majority of the helices are in an orientation that is consistent with a belt model, because most Trp residues localized to a position about 5 Å from the center of the bilayer. This study corroborates a belt hypothesis for the majority of the helices of apoA-I in phospholipid discs.

[1]  L. Sokoloff,et al.  Sterol to Phospholipid Molar Ratios of L Cells with Qualitative and Quantitative Variations of Cellular Sterol , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  W. J. Johnson,et al.  Cholesterol transport between cells and high-density lipoproteins. , 1991, Biochimica et biophysica acta.

[3]  A. Jonas,et al.  Structural organization of the N-terminal domain of apolipoprotein A-I: studies of tryptophan mutants. , 1999, Biochemistry.

[4]  M. Lefevre,et al.  Lipoproteins in interstitial fluid of dogs: implications for a role in reverse cholesterol transport. , 1990, European heart journal.

[5]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.

[6]  A. Gotto,et al.  The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I. , 1975, The Journal of biological chemistry.

[7]  N. Tolbert,et al.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.

[8]  W. J. Johnson,et al.  Effects of Acceptor Particle Size on the Efflux of Cellular Free Cholesterol (*) , 1995, The Journal of Biological Chemistry.

[9]  D. Lyles,et al.  Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer* , 2000, The Journal of Biological Chemistry.

[10]  J. Engler,et al.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Ruysschaert,et al.  Investigation of the lipid domains and apolipoprotein orientation in reconstituted high density lipoproteins by fluorescence and IR methods. , 1990, The Journal of biological chemistry.

[12]  C. Mann,et al.  Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase. , 1992, The Journal of clinical investigation.

[13]  T. Langmann,et al.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.

[14]  A. Vaughan,et al.  The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.

[15]  P. Axelsen,et al.  The Structure of Human Lipoprotein A-I , 1999, The Journal of Biological Chemistry.

[16]  A. Jonas,et al.  Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. , 1989, The Journal of biological chemistry.

[17]  G. Anantharamaiah,et al.  Structural models of human apolipoprotein A-I. , 1995, Biochimica et biophysica acta.

[18]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[19]  A. Mclachlan,et al.  Repeated helical pattern in apolipoprotein-A-I , 1977, Nature.

[20]  A. Jonas,et al.  Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: an alternative model based on fluorescence resonance energy transfer experiments. , 2001, Biochemistry.

[21]  G. Anantharamaiah,et al.  Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[22]  D. Sparks,et al.  The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. , 1992, The Journal of biological chemistry.

[23]  E. London,et al.  Parallax method for direct measurement of membrane penetration depth utilizing fluorescence quenching by spin-labeled phospholipids. , 1987, Biochemistry.

[24]  D. Atkinson,et al.  Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism. , 1992, Biophysical journal.

[25]  P. Wilson,et al.  Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. , 1994, Journal of lipid research.

[26]  W. Davidson,et al.  The Orientation of Helix 4 in Apolipoprotein A-I-containing Reconstituted High Density Lipoproteins* , 2000, The Journal of Biological Chemistry.

[27]  A. Jonas Reconstitution of high-density lipoproteins. , 1986, Methods in enzymology.

[28]  E. A. Burstein,et al.  FLUORESCENCE AND THE LOCATION OF TRYPTOPHAN RESIDUES IN PROTEIN MOLECULES , 1973, Photochemistry and photobiology.

[29]  R. Brasseur,et al.  Mode of assembly of amphipathic helical segments in model high-density lipoproteins. , 1990, Biochimica et biophysica acta.

[30]  Anthony E. Klon,et al.  A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein* , 1999, The Journal of Biological Chemistry.

[31]  E. London,et al.  Extension of the parallax analysis of membrane penetration depth to the polar region of model membranes: use of fluorescence quenching by a spin-label attached to the phospholipid polar headgroup. , 1993, Biochemistry.

[32]  R. Lawn,et al.  ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.

[33]  James C. Phillips,et al.  Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. , 1997, Biophysical journal.

[34]  H. Brewer,et al.  Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). , 1980, Annals of internal medicine.

[35]  J. Piette,et al.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.

[36]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.